<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5858838</article-id><article-id pub-id-type="pmid">29513667</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0006239</article-id><article-id pub-id-type="publisher-id">PNTD-D-17-01464</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Immunologic Techniques</subject><subj-group><subject>Immunoassays</subject><subj-group><subject>Enzyme-Linked Immunoassays</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Bolivia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Blood Donors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immunity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immunity</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Zika virus epidemiology in Bolivia: A seroprevalence study in volunteer blood donors</article-title><alt-title alt-title-type="running-head">Zika virus seroprevalence in Bolivian blood donors</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8695-5283</contrib-id><name><surname>Saba Villarroel</surname><given-names>Paola Mariela</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Nurtop</surname><given-names>Elif</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pastorino</surname><given-names>Boris</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Roca</surname><given-names>Yelin</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Drexler</surname><given-names>Jan Felix</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gallian</surname><given-names>Pierre</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jaenisch</surname><given-names>Thomas</given-names></name><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Leparc-Goffart</surname><given-names>Isabelle</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Priet</surname><given-names>St&#x000e9;phane</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ninove</surname><given-names>Laetitia</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Lamballerie</surname><given-names>Xavier</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>UMR EPV &#x000c9;mergence des Pathologies Virales, Aix-Marseille University&#x02014;IRD 190&#x02014;Inserm 1207 &#x02013;EHESP&#x02013;IHU M&#x000e9;diterran&#x000e9;e Infection, Marseille, France</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Virolog&#x000ed;a II, Centro Nacional de Enfermedades Tropicales (CENETROP), Santa Cruz de la Sierra, Bolivia</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>German Centre for Infection Research (DZIF) Charit&#x000e9;&#x02014;Universit&#x000e4;tsmedizin Berlin, Berlin, Germany</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Institute of Virology, Charit&#x000e9;&#x02014;Universit&#x000e4;tsmedizin Berlin, Berlin, Germany</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Laboratoire de Virologie, &#x000c9;tablissement Fran&#x000e7;ais du Sang Alpes M&#x000e9;diterran&#x000e9;e (EFS), Marseille, France</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Department for Infectious Diseases (Section Clinical Tropical Medicine), Heidelberg University Hospital, Heidelberg, Germany</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>National Reference Centre for Arboviruses, French Armed Forces Biomedical Research Institute, Marseille, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rodriguez-Barraquer</surname><given-names>Isabel</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of California San Francisco, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>marielasaba@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2018</year></pub-date><volume>12</volume><issue>3</issue><elocation-id>e0006239</elocation-id><history><date date-type="received"><day>14</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Saba Villarroel et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Saba Villarroel et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0006239.pdf"/><abstract><sec id="sec001"><title>Background</title><p>Zika virus (ZIKV), was widely reported in Latin America and has been associated with neuropathologies, as microcephaly, but only few seroprevalence studies have been published to date. Our objective was to determine the seroprevalence amongst Bolivian blood donors and estimate the future potential circulation of the virus.</p></sec><sec id="sec002"><title>Methodology</title><p>A ZIKV seroprevalence study was conducted between December 2016 and April 2017 in 814 asymptomatic Bolivian volunteer blood donors residing in various eco-environments corresponding to contrasting entomological activities. It was based on detection of IgG to ZIKV using NS1 ELISA screening, followed by a seroneutralisation test in case of positive or equivocal ELISA result.</p></sec><sec id="sec003"><title>Conclusions/Significance</title><p>Analysis revealed that ZIKV circulation occurred in tropical areas (Beni: 39%; Santa Cruz de la Sierra: 21.5%) but not in highlands (~0% in Cochabamba, La Paz, Tarija). It was modulated by <italic>Aedes aegypti</italic> activity and the virus spread was not limited by previous immunity to dengue. Cases were geo-localised in a wide range of urban areas in Santa Cruz and Trinidad. No differences in seroprevalence related to gender or age-groups could be identified. It is concluded that ZIKV has been intensely circulating in the Beni region and has still a significant potential for propagating in the area of Santa Cruz.</p></sec></abstract><abstract abstract-type="summary"><title>Author summary</title><p>Zika virus (ZIKV) is a virus of African origin, transmitted by <italic>Aedes</italic> mosquitoes, and related to dengue and yellow fever virus. It was originally believed to be responsible for a mild febrile illness in Africa and South-east Asia. However, in recent years, ZIKV has been responsible for outbreaks in the Pacific Islands before massively spreading in Latin America and the Caribbean. On this occasion, ZIKV has unexpectedly been associated with non-vector transmission (<italic>i</italic>.<italic>e</italic>., sexual and mother-to-foetus transmission) and with severe complications such as foetal abnormalities <italic>(e</italic>.<italic>g</italic>. microcephaly) and Guillain-Barr&#x000e9; syndromes.</p><p>Little is known about the actual proportion of the populations infected by ZIKV in Latin America. Here, we report a seroprevalence data in this region, after studying 814 asymptomatic Bolivian volunteer blood donors residing in various eco-environments corresponding to contrasting entomological activities. We conclude that ZIKV has been circulating in Bolivian tropical areas but not in highlands, and that the epidemic has not been limited by previous immunity against dengue. Specific attention should be paid to the region of Santa Cruz, where the seroprevalence is still limited, but the density of <italic>Aedes aegypti</italic> populations makes plausible further spreading of the disease.</p></abstract><funding-group><funding-statement>This work was supported in part by the European Union&#x02019;s Horizon 2020 research and innovation programmes ZIKAlliance and EVAg under grant agreements No 734548 and 653316, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="1"/><page-count count="9"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2018-03-19</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec004"><title>Introduction</title><p>Zika virus (ZIKV) is an arthropod-borne <italic>Flavivirus</italic> transmitted to humans mainly by <italic>Aedes</italic> mosquitoes. It has been responsible over the last decade for outbreaks in Pacific Islands [<xref rid="pntd.0006239.ref001" ref-type="bibr">1</xref>] (Yap Island, 2007 [<xref rid="pntd.0006239.ref002" ref-type="bibr">2</xref>]; French Polynesia, 2013 [<xref rid="pntd.0006239.ref003" ref-type="bibr">3</xref>]; New Caledonia, Cook Islands and Easter Island, 2014 [<xref rid="pntd.0006239.ref004" ref-type="bibr">4</xref>]; Vanuatu, Solomon Islands, Samoa and Fiji, 2015 [<xref rid="pntd.0006239.ref005" ref-type="bibr">5</xref>]), in Latin America (from late 2013 [<xref rid="pntd.0006239.ref006" ref-type="bibr">6</xref>] or early 2014 [<xref rid="pntd.0006239.ref007" ref-type="bibr">7</xref>] in Brazil, then in a large number of other countries [<xref rid="pntd.0006239.ref008" ref-type="bibr">8</xref>]), and in the Caribbean region (<italic>e</italic>.<italic>g</italic>., 2014 in Haiti [<xref rid="pntd.0006239.ref009" ref-type="bibr">9</xref>], 2015 in Martinique Island [<xref rid="pntd.0006239.ref010" ref-type="bibr">10</xref>]). The first autochthonous case reported in Bolivia was in January 2016 [<xref rid="pntd.0006239.ref011" ref-type="bibr">11</xref>].</p><p>ZIKV is of African origin, but an Asian lineage emerged presumably in the first part of the XIX<sup>th</sup> century [<xref rid="pntd.0006239.ref006" ref-type="bibr">6</xref>] and the viruses that spread in the Pacific and the Americas are descendants of this lineage. In addition to the classical picture of large arboviral outbreaks, significant public health burden was endured in Polynesia and America when severe and formerly undescribed foetal and neurological complications of the disease [<xref rid="pntd.0006239.ref012" ref-type="bibr">12</xref>] as well as non-vectored routes of transmission [<xref rid="pntd.0006239.ref013" ref-type="bibr">13</xref>] were reported.</p><p>Our capacity to estimate the future spread of ZIKV disease in South America significantly depends on our knowledge of the immune status against ZIKV in the populations exposed to the potential vectors (mostly <italic>Aedes aegypti</italic> mosquitoes). Few ZIKV seroprevalence results in the region have been made available yet, most probably due to the technical difficulty to distinguish antibodies to ZIKV from cross-reacting antibodies to the other flaviviruses, in particular dengue virus. Specific detection of antibodies to ZIKV can be improved when using demanding seroneutralisation methods for the primary detection of antibodies, or for confirmation of a more convenient screening assay such as an ELISA test.</p><p>In this context, we investigated the ZIKV serological status of blood donors from different regions of Bolivia and analysed results with reference to immunity of the same populations to dengue (DENV) and chikungunya virus (CHIKV), two arboviruses known to be transmitted by the same vector locally. DENV has been reported in Bolivia since 1931. In 1948, Bolivia was declared <italic>Ae</italic>. <italic>aegypti</italic> free, but the vector reappeared in the 1980s. Since then, DENV-1, DENV-2, DENV-3, lately DENV-4 and the co-circulation of serotypes have been reported, being massively endemic in the tropical regions of Bolivia [<xref rid="pntd.0006239.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0006239.ref015" ref-type="bibr">15</xref>]. CHIKV, a member of the <italic>Alphavirus</italic> genus arrived in the Caribbean in late 2013 and then spread through Latin America the following years, causing explosive outbreaks in humans[<xref rid="pntd.0006239.ref016" ref-type="bibr">16</xref>].</p></sec><sec sec-type="materials|methods" id="sec005"><title>Methods</title><sec id="sec006"><title>Sample collection</title><p>We conducted a study with the help of five Bolivian regional blood banks, representing a variety of eco-environments (Santa Cruz de la Sierra and Beni have tropical climate; Cochabamba, Tarija and La Paz have colder subtropical highland climates): 814 volunteer blood donors from Santa Cruz de la Sierra (n = 200), La Paz (n = 161), Cochabamba (n = 152), Tarija (n = 196), and Beni (n = 105) provided before blood donation their oral consent for detection of IgG to ZIKV. All donors accepting to participate in the study and providing consent were considered eligible. No specific sampling was performed and leftovers of blood samples collected and stored at -20&#x000b0;C after completion of laboratory analyses were used. The contribution of each site was evaluated locally according to the actual possibilities to recruit donors, process samples and provide the epidemiological data requested (see below). The sample size was in agreement with previous epidemiological studies of arbovirus seroprevalence in other countries and expected to provide a reliable picture of the global epidemiological situation [<xref rid="pntd.0006239.ref017" ref-type="bibr">17</xref>, <xref rid="pntd.0006239.ref010" ref-type="bibr">10</xref>]. Sampling was performed in December 2016 in the Beni region, then from March to April 2017 in the other sites, according to local logistical possibilities.</p></sec><sec id="sec007"><title>Ethics statement</title><p>Blood samples and personal data (date of donation, sex, age, birthplace, living place, occupation and neighbourhood) were irreversibly anonymised.</p><p>Adults blood donors approved to participate in the study by providing oral consent during the face-to-face questioning before blood gift. This procedure was considered the most suitable by local blood banks. The sampling and analysis protocol was approved by the ethics committee of the Medical College of Santa Cruz.</p></sec><sec id="sec008"><title>Serological analysis</title><p>Samples were tested for the presence of IgG to ZIKV as previously described [<xref rid="pntd.0006239.ref010" ref-type="bibr">10</xref>,<xref rid="pntd.0006239.ref017" ref-type="bibr">17</xref>]. In brief, alike Netto and collaborators[<xref rid="pntd.0006239.ref018" ref-type="bibr">18</xref>] we performed an initial screening with a recombinant NS1-based ELISA test (Euroimmun, L&#x000fc;beck, Germany) [<xref rid="pntd.0006239.ref019" ref-type="bibr">19</xref>, <xref rid="pntd.0006239.ref020" ref-type="bibr">20</xref>] which is the only test certified for serological diagnostics of ZIKV by the responsible Brazilian authority ANVISA (Ag&#x000ea;ncia Nacional de Vigil&#x000e2;ncia Sanit&#x000e1;ria)[<xref rid="pntd.0006239.ref018" ref-type="bibr">18</xref>] and a subsequent Virus Neutralisation Test (VNT) for samples with a positive or equivocal ELISA result (ratio &#x02265;0.8). VNT was performed in a 96-well format based on cytopathic effect (CPE), using ZIKV strain H/PF/2013[<xref rid="pntd.0006239.ref021" ref-type="bibr">21</xref>], Vero ATCC cells monolayers and serum dilutions from 1:10 to 1:320. All samples were tested in duplicate with positive and negative serum controls. Sera with titre &#x02265;1:40 were considered positive, according to the recommendations of the French National Reference Centre for Arboviruses. This testing strategy was previously demonstrated to provide specificity and sensitivity values above 98.5% in volunteer blood donors of Martinique Island tested before, during, and after the 2016 ZIKV outbreak[<xref rid="pntd.0006239.ref022" ref-type="bibr">22</xref>] and with heavy exposure to dengue[<xref rid="pntd.0006239.ref023" ref-type="bibr">23</xref>].</p><p>To estimate the serological immune background against dengue and chikungunya (which in Bolivia are also transmitted by <italic>Aedes aegypti</italic>), we randomly selected approximately half of the samples on each site (Beni, n = 60; Santa Cruz de la Sierra, n = 108; Tarija, n = 111; La Paz, n = 93; Cochabamba, n = 77; <italic>i</italic>.<italic>e</italic>., 449 in total). They were tested for the presence of IgG to DENV and CHIKV (Euroimmun dengue ELISA IgG and chikungunya ELISA IgG assays) according to the manufacturer's recommendations.</p><p>Donors were assigned for analysis to 3 age-groups (18&#x02013;30 years-old; 31-40yo; 41-60yo) and 6 ZIKV ELISA ratio groups (&#x0003c;0.8; 0.8&#x02013;1.09; 1.1&#x02013;2.49; 2.5&#x02013;3.99; 4.0&#x02013;5.49; &#x02265;5.5).</p><p>Statistical analyses were performed using IBM-SPSS Statistics v 24.0.0.0 software. Statistical association between ZIKV seropositivity and age-group or gender was evaluated, as well as relationship between ZIKV seropositivity and DENV or CHIKV seropositivity (Chi square test, significant threshold: p = 0.05).</p><sec id="sec009"><title>Accession numbers</title><p>Zika virus strain H/PF/2013: KJ776791.2</p></sec></sec></sec><sec id="sec010"><title>Results and discussion</title><p>Serological results in the different sites for ZIKV are shown in <xref ref-type="fig" rid="pntd.0006239.g001">Fig 1</xref>. ZIKV has been circulating in the two regions with a typical tropical climate (Beni and Santa Cruz de la Sierra), but not in highlands in which the entomological activity is limited. In the tropical regions, the usual period of circulation of <italic>Aedes</italic> borne viruses ranges from November to April. The high seroprevalence rate in Beni (39% after VNT, (95% CI [30%&#x02013;48%])) is in agreement with the report of an outbreak of febrile cases with rash locally, with laboratory PCR confirmed cases before our study (performed in December 2016). Since cases were reported in Beni until the end of the rainy season, it is likely that the final seroprevalence rate is even higher nowadays in this region.</p><fig id="pntd.0006239.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006239.g001</object-id><label>Fig 1</label><caption><title>Zika virus seroprevalence in Bolivian volunteer blood donors.</title><p>Samples were collected in December 2016 (Beni) and from March to April 2017 (other regions). The figure shows in each of the five regions investigated the proportion of samples positives in both ELISA and Virus Neutralisation Test (the black circle represents the proportion of positives): Santa Cruz (altitude ~400m) and Beni (alt. ~150m) have tropical climate; Cochabamba (alt. ~2500m), Tarija (alt. ~1850m), and especially La Paz (alt. ~3650m) have colder subtropical highland climates.</p></caption><graphic xlink:href="pntd.0006239.g001"/></fig><p>The significant rate in Santa Cruz (21.5% after VNT, (95% CI [16%-27%])) is in line with the report of PCR confirmed cases locally before the collection of samples (in March and April 2017). Detection of cases benefitted from the local implementation of the Cenetrop National Reference Laboratory, but no clear epidemic pattern was reported. Since the study was performed locally at the end of the rainy season, it is most probable that the seroprevalence rate remained locally at a lower level than in Beni.</p><p>Of note, the proportion of ELISA positives confirmed by VNT was much higher in Beni than in Santa Cruz (63.1% <italic>vs</italic> 35.2%), possibly reflecting the frequent and intense immune stimulation against ZIKV in the Beni population.</p><p>When examining the relationship between ZIKV ELISA and VNT results, it appears, as previously observed [<xref rid="pntd.0006239.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0006239.ref017" ref-type="bibr">17</xref>], that the rate of VNT confirmation increases with the value of the ELISA ratio, reaching 65% for an ELISA ratio &#x02265;4 and 95% for an ELISA ratio &#x02265;5.5 (<xref ref-type="supplementary-material" rid="pntd.0006239.s002">S1 Table</xref>).</p><p><xref ref-type="table" rid="pntd.0006239.t001">Table 1</xref> shows the distribution of seropositives per site with the background of serological results for dengue and chikungunya, which circulation in Bolivia has been widely documented. Immunity to dengue virus is the rule in the tropical regions (&#x0003e;90% of seropositives in Beni and Santa Cruz), but also significant in the region of Tarija (44.1%). It is more limited in Cochabamba and La Paz (<italic>ca</italic> ~10%). For chikungunya, approximately half of the population is seropositive in the tropical regions and less than 10% in highlands. The differences observed with dengue most probably reflect the lower number of epidemic waves of chikungunya that hit the country. Dengue was first reported in Bolivia in 1931 and since then has been circulating intensely with major epidemics in the tropical regions[<xref rid="pntd.0006239.ref015" ref-type="bibr">15</xref>] and, over time, multiple imported cases and possibly transient local transmission in highlands (in particular the Tarija region). By contrast, autochthonous transmission of CHIKV was first reported in Bolivia as recently as 2015 following the introduction of the virus in the Americas[<xref rid="pntd.0006239.ref024" ref-type="bibr">24</xref>], limiting herd immunity outside the areas of intense epidemic transmission. Altogether, the spreading pattern of ZIKV follows that of other <italic>Aedes aegypti</italic>-borne viruses in Bolivia, in particular that of the recently introduced CHIKV.</p><table-wrap id="pntd.0006239.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006239.t001</object-id><label>Table 1</label><caption><title>Serological results for Zika, dengue and chikungunya in Bolivian blood donors.</title></caption><alternatives><graphic id="pntd.0006239.t001g" xlink:href="pntd.0006239.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">IgG ELISA</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Total<break/>No.</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Positive<break/>No. (% [95% CI])</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Equivocal<break/>No. (%)</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Negative<break/>No. (%)</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">VNT<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">No.</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Positive<break/>No. (% [95% CI])</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">VNT/ELISA<break/>(%)</th></tr></thead><tbody><tr><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Zika</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Zika</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Beni</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">105</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">65 (61.9)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">5 (4.8)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">35 (33.3)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">70</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">41 (39.0 [30&#x02013;48])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">63.1</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Santa Cruz</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">200</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">122 (61.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">12 (6.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">66 (33.0)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">134</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">43 (21.5 [16&#x02013;27])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">35.2</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Tarija</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">196</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">19 (9.7)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">3 (1.5)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">174 (88.8)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">22</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1 (0.5 0&#x02013;1.5])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">5.3</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>La Paz</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">162</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">3 (1.9)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1 (0.6)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">157 (96.9)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">4</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Cochabamba</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">152</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">4 (2.6)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">3 (2.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">145 (95.4)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">7</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.0</td></tr><tr><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Chikungunya</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Beni</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">60</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">28 (46.7 [34&#x02013;59])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">32 (53.3)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Santa Cruz</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">108</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">59 (54.6 [45&#x02013;64])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1 (0.9)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">48 (44.4)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Tarija</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">111</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">6 (5.4 1&#x02013;10])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">105 (94.6)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>La Paz</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">93</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">3 (3.2 0&#x02013;7])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">90 (96.8)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Cochabamba</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">77</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">6 (7.8 2&#x02013;14])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">71 (92.2)</td></tr><tr><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Dengue</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Beni</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">60</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">54 (90.0 [82&#x02013;98])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">6 (10.0)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Santa Cruz</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">108</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">101 (93.5 [89&#x02013;98])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1 (0.9)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">6 (5.6)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Tarija</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">111</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">49 (44.1 [35&#x02013;53])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">3 (2.7)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">59 (53.2)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>La Paz</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">93</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">11 (11.8 5&#x02013;18])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">82 (88.2)</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Cochabamba</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">77</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">8 (10.4 4&#x02013;17])</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">0 (0.0)</td><td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">69 (89.6)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Serology for Zika virus was performed for the complete population of the study using a commercial NS1-based IgG ELISA screening assay followed by a Virus Neutralisation Test (VNT) for samples with ELISA positive or equivocal results. Serology for dengue and chikungunya viruses was performed for a randomly selected sample corresponding to <italic>ca</italic>. fifty per cent of the complete population studied. Testing was performed with commercial assays using purified virus particles (dengue) and recombinant proteins (chikungunya) as viral antigens. Percentages are expressed as the proportion of positives in the total population tested in ELISA.</p></fn><fn id="t001fn002"><p><sup><bold>a</bold></sup>Virus Neutralisation test</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="supplementary-material" rid="pntd.0006239.s003">S2 Table</xref> details the distribution of seropositives for ZIKV, DENV and CHIKV according to sex and age groups. Differences are minimal between groups (none reaches a significance threshold of 0.05), suggesting that age and sex do not significantly impact exposure to these arboviral diseases in the population investigated. Importantly, there is in the population studied a strong relationship between seropositivity to ZIKV and to DENV (p&#x0003c;10<sup>&#x02212;12</sup>), but also to CHIKV (p&#x0003c;10<sup>&#x02212;15</sup>), obviously pointing to exposure to a common risk factor: the bite of the <italic>Aedes aegypti</italic> vector of the three diseases.</p><p>This study has classical limitations linked to the sampling procedure in blood donors (in particular data regarding individuals under the age of 15 years old and in pregnant women could not be obtained). However, many previous studies on arboviruses including dengue virus[<xref rid="pntd.0006239.ref023" ref-type="bibr">23</xref>] chikungunya virus[<xref rid="pntd.0006239.ref025" ref-type="bibr">25</xref>], Zika virus [<xref rid="pntd.0006239.ref010" ref-type="bibr">10</xref>] have suggested that blood donors constitute a valuable population to identify the major epidemiological trends that underlie exposure to arbovirus transmission and spread. Amongst great advantages of studying blood donor's populations, one can mention the logistical capability to perform rapidly multisite studies in the absence of robust local research infrastructure, the absence of the need to perform specific sampling, and the access to comparable populations in multiple sites that allows comparison of prevalence values.</p><p>We conclude that this seroprevalence study confirms the circulation of Zika virus in Bolivia. Despite previous reports of the presence of <italic>A</italic>. <italic>aegypti</italic> in all 5 departments investigated [<xref rid="pntd.0006239.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0006239.ref026" ref-type="bibr">26</xref>, <xref rid="pntd.0006239.ref027" ref-type="bibr">27</xref>, <xref rid="pntd.0006239.ref028" ref-type="bibr">28</xref>, <xref rid="pntd.0006239.ref029" ref-type="bibr">29</xref>], the potential for epidemic spread is deeply modulated by the variable entomological activity in the different locations, in relation with different eco-environments (and in particular different altitudes) and as reflected by contrasted exposure to dengue or chikungunya. In the tropical areas of Santa Cruz and Beni, <ext-link ext-link-type="uri" xlink:href="https://www.mapcustomizer.com/map/Zika%20IgG%20Bolivia%20?utm_source=share&#x00026;utm_medium=email">cases were identified from the city centres to outlying district</ext-link>, reflecting the wide distribution of <italic>A</italic>. <italic>aegypti</italic>. According to previous information relating to the circulation of dengue in Bolivia and corroborated by our present seroprevalence data, the spread of Zika virus was not limited by previous herd immunity to dengue virus. However, it remains possible that prior immunity to DENV modified the epidemiological pattern of the virus global spread.</p><p>The same methodological protocol has been used previously to estimate ZIKV seroprevalence in Martinique Island [<xref rid="pntd.0006239.ref010" ref-type="bibr">10</xref>] (Caribbean region) and Cameroon[<xref rid="pntd.0006239.ref017" ref-type="bibr">17</xref>] (Central Africa). Clearly, the transmission pattern in Bolivia is very different from the (peri-)sylvatic transmission reported in Cameroon, and more closely related to the urban transmission by the (peri-)domestic <italic>A</italic>. <italic>aegypti</italic> in Martinique. With reference to the Martinique outbreak and seroprevalence study, a minimum seroprevalence rate around 50% seems to be required to provide herd immunity that can stop ZIKV circulation. Accordingly, the ~21% rate observed in Santa Cruz (in the last phase of the arbovirus circulation period) would be insufficient to give protective herd immunity in the presence of abundant potential vectors and intense entomological activity, and with sustained circulation and potential reintroduction of the virus in Latin America. It is therefore expected that ZIKV circulation should be limited in the near future in the Beni Region (data were collected in December and the virus could circulate for at least four additional months locally, therefore the final seroprevalence rate may be even higher), but, in contrast, ecological and epidemiological conditions are favourable for further circulation of the virus in Santa Cruz, with its consequent complications especially in pregnant women.</p></sec><sec sec-type="supplementary-material" id="sec011"><title>Supporting information</title><supplementary-material content-type="local-data" id="pntd.0006239.s001"><label>S1 Checklist</label><caption><title>STROBE checklist.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006239.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006239.s002"><label>S1 Table</label><caption><title>Relation between ELISA ratio and Virus Neutralisation Test.</title><p>(DOCX)</p></caption><media xlink:href="pntd.0006239.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006239.s003"><label>S2 Table</label><caption><title>Seropositivity for Zika, dengue and chikungunya virus, according to sex and age group.</title><p>Prevalence between males and females were compared for each site and globally using the chi-square test and were insignificant for p-value at 0.05.</p><p>(DOCX)</p></caption><media xlink:href="pntd.0006239.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are grateful to Loreto Saavedra, Mar&#x000ed;a Luisa Herrera Rivera, Yitzhak Leigue Zabala, Fabiana Escalante, Mar&#x000ed;a del Carmen Garc&#x000ed;a, Vanessa Teller&#x000ed;a, Liliana Navarro, and Etzel Arancibia Cardozo from the regional Bolivian blood banks, for their help in collecting serum samples. We are deeply indebted to Christine Isnard for technical assistance in serological testing.</p></ack><ref-list><title>References</title><ref id="pntd.0006239.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Musso</surname><given-names>D</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>. <article-title>Zika Virus</article-title>. <source>Clin Microbiol Rev</source>. <year>2016</year>;<volume>29</volume>: <fpage>487</fpage>&#x02013;<lpage>524</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/CMR.00072-15">10.1128/CMR.00072-15</ext-link></comment>
<?supplied-pmid 27029595?><pub-id pub-id-type="pmid">27029595</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Duffy</surname><given-names>MR</given-names></name>, <name><surname>Chen</surname><given-names>T-H</given-names></name>, <name><surname>Hancock</surname><given-names>WT</given-names></name>, <name><surname>Powers</surname><given-names>AM</given-names></name>, <name><surname>Kool</surname><given-names>JL</given-names></name>, <name><surname>Lanciotti</surname><given-names>RS</given-names></name>, <etal>et al</etal>
<article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>: <fpage>2536</fpage>&#x02013;<lpage>2543</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa0805715">10.1056/NEJMoa0805715</ext-link></comment>
<?supplied-pmid 19516034?><pub-id pub-id-type="pmid">19516034</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref003"><label>3</label><mixed-citation publication-type="other">Al VC-L et. Zika Virus, French Polynesia, South Pacific, 2013&#x02014;Volume 20, Number 6&#x02014;June 2014&#x02014;Emerging Infectious Disease journal&#x02014;CDC. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2006.140138">10.3201/eid2006.140138</ext-link></comment></mixed-citation></ref><ref id="pntd.0006239.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Musso</surname><given-names>D</given-names></name>, <name><surname>Nilles</surname><given-names>EJ</given-names></name>, <name><surname>Cao-Lormeau</surname><given-names>V-M</given-names></name>. <article-title>Rapid spread of emerging Zika virus in the Pacific area</article-title>. <source>Clin Microbiol Infect</source>. <year>2014</year>;<volume>20</volume>: <fpage>O595</fpage>&#x02013;<lpage>O596</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1469-0691.12707">10.1111/1469-0691.12707</ext-link></comment>
<?supplied-pmid 24909208?><pub-id pub-id-type="pmid">24909208</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref005"><label>5</label><mixed-citation publication-type="book"><collab>WPRO</collab> | <chapter-title>Emerging disease surveillance and response</chapter-title> In: <publisher-name>WPRO</publisher-name> [Internet]. Available: <ext-link ext-link-type="uri" xlink:href="http://www.wpro.who.int/southpacific/programmes/communicable_diseases/disease_surveillance_response/page/en/">http://www.wpro.who.int/southpacific/programmes/communicable_diseases/disease_surveillance_response/page/en/</ext-link></mixed-citation></ref><ref id="pntd.0006239.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Pettersson</surname><given-names>JH-O</given-names></name>, <name><surname>Eldholm</surname><given-names>V</given-names></name>, <name><surname>Seligman</surname><given-names>SJ</given-names></name>, <name><surname>Lundkvist</surname><given-names>&#x000c5;</given-names></name>, <name><surname>Falconar</surname><given-names>AK</given-names></name>, <name><surname>Gaunt</surname><given-names>MW</given-names></name>, <etal>et al</etal>
<article-title>How Did Zika Virus Emerge in the Pacific Islands and Latin America?</article-title>
<source>mBio</source>. <year>2016</year>;<fpage>7</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.01239-16">10.1128/mBio.01239-16</ext-link></comment>
<?supplied-pmid 27729507?><pub-id pub-id-type="pmid">27729507</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>Quick</surname><given-names>J</given-names></name>, <name><surname>Claro</surname><given-names>IM</given-names></name>, <name><surname>Th&#x000e9;z&#x000e9;</surname><given-names>J</given-names></name>, <name><surname>de Jesus</surname><given-names>JG</given-names></name>, <name><surname>Giovanetti</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Establishment and cryptic transmission of Zika virus in Brazil and the Americas</article-title>. <source>Nature</source>. <year>2017</year>;<volume>546</volume>: <fpage>406</fpage>&#x02013;<lpage>410</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature22401">10.1038/nature22401</ext-link></comment>
<?supplied-pmid 28538727?><pub-id pub-id-type="pmid">28538727</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref008"><label>8</label><mixed-citation publication-type="book"><name><surname>Sanchez</surname><given-names>JD</given-names></name>. <collab>PAHO WHO</collab> | <chapter-title>Regional Zika Epidemiological Update (Americas) July 26, 2017</chapter-title> In: <publisher-name>Pan American Health Organization / World Health Organization</publisher-name> [Internet]. <day>27</day>
<month>7</month>
<year>2017</year> Available: <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=11599:regional-zika-epidemiological-update-americas&#x00026;catid=8424:contents&#x00026;Itemid=41691&#x00026;lang=fr">http://www.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=11599:regional-zika-epidemiological-update-americas&#x00026;catid=8424:contents&#x00026;Itemid=41691&#x00026;lang=fr</ext-link></mixed-citation></ref><ref id="pntd.0006239.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Lednicky</surname><given-names>J</given-names></name>, <name><surname>Beau De Rochars</surname><given-names>VM</given-names></name>, <name><surname>El Badry</surname><given-names>M</given-names></name>, <name><surname>Loeb</surname><given-names>J</given-names></name>, <name><surname>Telisma</surname><given-names>T</given-names></name>, <name><surname>Chavannes</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Outbreak in Haiti in 2014: Molecular and Clinical Data</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>: <fpage>e0004687</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pntd.0004687">10.1371/journal.pntd.0004687</ext-link></comment>
<?supplied-pmid 27111294?><pub-id pub-id-type="pmid">27111294</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Gallian</surname><given-names>P</given-names></name>, <name><surname>Cabi&#x000e9;</surname><given-names>A</given-names></name>, <name><surname>Richard</surname><given-names>P</given-names></name>, <name><surname>Paturel</surname><given-names>L</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>, <name><surname>Pastorino</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Zika virus in asymptomatic blood donors in Martinique</article-title>. <source>Blood</source>. <year>2017</year>;<volume>129</volume>: <fpage>263</fpage>&#x02013;<lpage>266</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2016-09-737981">10.1182/blood-2016-09-737981</ext-link></comment>
<?supplied-pmid 27827826?><pub-id pub-id-type="pmid">27827826</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref011"><label>11</label><mixed-citation publication-type="book"><collab>OMS</collab> | <chapter-title>Infecci&#x000f3;n por el virus de Zika&#x02014;Bolivia</chapter-title> In: <publisher-name>WHO</publisher-name> [Internet]. [cited 31 Oct 2017]. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/20-january-2016-zika-bolivia/es/">http://www.who.int/csr/don/20-january-2016-zika-bolivia/es/</ext-link></mixed-citation></ref><ref id="pntd.0006239.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Saucedo-Cuevas</surname><given-names>L</given-names></name>, <name><surname>Shresta</surname><given-names>S</given-names></name>, <name><surname>Gleeson</surname><given-names>JG</given-names></name>. <article-title>The Neurobiology of Zika Virus</article-title>. <source>Neuron</source>. <year>2016</year>;<volume>92</volume>: <fpage>949</fpage>&#x02013;<lpage>958</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuron.2016.11.031">10.1016/j.neuron.2016.11.031</ext-link></comment>
<?supplied-pmid 27930910?><pub-id pub-id-type="pmid">27930910</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Grischott</surname><given-names>F</given-names></name>, <name><surname>Puhan</surname><given-names>M</given-names></name>, <name><surname>Hatz</surname><given-names>C</given-names></name>, <name><surname>Schlagenhauf</surname><given-names>P</given-names></name>. <article-title>Non-vector-borne transmission of Zika virus: A systematic review</article-title>. <source>Travel Med Infect Dis</source>. <year>2016</year>;<volume>14</volume>: <fpage>313</fpage>&#x02013;<lpage>330</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tmaid.2016.07.002">10.1016/j.tmaid.2016.07.002</ext-link></comment>
<?supplied-pmid 27425793?><pub-id pub-id-type="pmid">27425793</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Br&#x000e9;mond</surname><given-names>P</given-names></name>, <name><surname>Roca</surname><given-names>Y</given-names></name>, <name><surname>Breni&#x000e8;re</surname><given-names>SF</given-names></name>, <name><surname>Walter</surname><given-names>A</given-names></name>, <name><surname>Barja-Simon</surname><given-names>Z</given-names></name>, <name><surname>Fern&#x000e1;ndez</surname><given-names>RT</given-names></name>, <etal>et al</etal>
<article-title>Evolution of Dengue Disease and Entomological Monitoring in Santa Cruz, Bolivia 2002&#x02013;2008</article-title>. <source>PLoS ONE</source>. <year>2015</year>;<fpage>10</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0118337">10.1371/journal.pone.0118337</ext-link></comment>
<?supplied-pmid 25706631?><pub-id pub-id-type="pmid">25706631</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Roca</surname><given-names>Y</given-names></name>, <name><surname>Baronti</surname><given-names>C</given-names></name>, <name><surname>Revollo</surname><given-names>RJ</given-names></name>, <name><surname>Cook</surname><given-names>S</given-names></name>, <name><surname>Loayza</surname><given-names>R</given-names></name>, <name><surname>Ninove</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Molecular epidemiological analysis of dengue fever in Bolivia from 1998 to 2008</article-title>. <source>Vector Borne Zoonotic Dis Larchmt N</source>. <year>2009</year>;<volume>9</volume>: <fpage>337</fpage>&#x02013;<lpage>344</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/vbz.2008.0187">10.1089/vbz.2008.0187</ext-link></comment>
<?supplied-pmid 19505253?><pub-id pub-id-type="pmid">19505253</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>E</given-names></name>, <name><surname>Pettersson</surname><given-names>J</given-names></name>, <name><surname>Higgs</surname><given-names>S</given-names></name>, <name><surname>Charrel</surname><given-names>R</given-names></name>, <name><surname>de Lamballerie</surname><given-names>X</given-names></name>. <article-title>Emerging arboviruses: Why today?</article-title>
<source>One Health</source>. <year>2017</year>;<volume>4</volume>: <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.onehlt.2017.06.001">10.1016/j.onehlt.2017.06.001</ext-link></comment>
<?supplied-pmid 28785601?><pub-id pub-id-type="pmid">28785601</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Gake</surname><given-names>B</given-names></name>, <name><surname>Vernet</surname><given-names>MA</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name><surname>Drexler</surname><given-names>JF</given-names></name>, <name><surname>Gould</surname><given-names>EA</given-names></name>, <name><surname>Gallian</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Low seroprevalence of Zika virus in Cameroonian blood donors</article-title>. <source>Braz J Infect Dis</source>. <year>2017</year>;<volume>21</volume>: <fpage>481</fpage>&#x02013;<lpage>483</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bjid.2017.03.018">10.1016/j.bjid.2017.03.018</ext-link></comment>
<?supplied-pmid 28549857?><pub-id pub-id-type="pmid">28549857</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Netto</surname><given-names>EM</given-names></name>, <name><surname>Moreira-Soto</surname><given-names>A</given-names></name>, <name><surname>Pedroso</surname><given-names>C</given-names></name>, <name><surname>H&#x000f6;ser</surname><given-names>C</given-names></name>, <name><surname>Funk</surname><given-names>S</given-names></name>, <name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <etal>et al</etal>
<article-title>High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks</article-title>. <source>mBio</source>. <year>2017</year>;<fpage>8</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.01390-17">10.1128/mBio.01390-17</ext-link></comment>
<?supplied-pmid 29138300?><pub-id pub-id-type="pmid">29138300</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Steinhagen</surname><given-names>K</given-names></name>, <name><surname>Probst</surname><given-names>C</given-names></name>, <name><surname>Radzimski</surname><given-names>C</given-names></name>, <name><surname>Schmidt-Chanasit</surname><given-names>J</given-names></name>, <name><surname>Emmerich</surname><given-names>P</given-names></name>, <name><surname>van Esbroeck</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016</article-title>. <source>Eurosurveillance</source>. <year>2016</year>;<fpage>21</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2807/1560-7917.ES.2016.21.50.30426">10.2807/1560-7917.ES.2016.21.50.30426</ext-link></comment>
<?supplied-pmid 28006649?><pub-id pub-id-type="pmid">28006649</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Huzly</surname><given-names>D</given-names></name>, <name><surname>Hanselmann</surname><given-names>I</given-names></name>, <name><surname>Schmidt-Chanasit</surname><given-names>J</given-names></name>, <name><surname>Panning</surname><given-names>M</given-names></name>. <article-title>High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses</article-title>. <source>Eurosurveillance</source>. <year>2016</year>;<volume>21</volume>: <fpage>30203</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2807/1560-7917.ES.2016.21.16.30203">10.2807/1560-7917.ES.2016.21.16.30203</ext-link></comment>
<?supplied-pmid 27126052?><pub-id pub-id-type="pmid">27126052</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Baronti</surname><given-names>C</given-names></name>, <name><surname>Piorkowski</surname><given-names>G</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>, <name><surname>Boubis</surname><given-names>L</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name><surname>de Lamballerie</surname><given-names>X</given-names></name>. <article-title>Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013</article-title>. <source>Genome Announc</source>. <year>2014</year>;<fpage>2</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/genomeA.00500-14">10.1128/genomeA.00500-14</ext-link></comment>
<?supplied-pmid 24903869?><pub-id pub-id-type="pmid">24903869</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref022"><label>22</label><mixed-citation publication-type="other">de Lamballerie X. Zika Virus sero-epidemiological studies. 8th European Meeting on Viral Zoonoses, October 22&#x02013;25, 2017, St. Rapha&#x000eb;l, France</mixed-citation></ref><ref id="pntd.0006239.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>L&#x02019;Azou</surname><given-names>M</given-names></name>, <name><surname>Jean-Marie</surname><given-names>J</given-names></name>, <name><surname>Bessaud</surname><given-names>M</given-names></name>, <name><surname>Cabi&#x000e9;</surname><given-names>A</given-names></name>, <name><surname>C&#x000e9;saire</surname><given-names>R</given-names></name>, <name><surname>de Lamballerie</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Dengue seroprevalence in the French West Indies: a prospective study in adult blood donors</article-title>. <source>Am J Trop Med Hyg</source>. <year>2015</year>;<volume>92</volume>: <fpage>1137</fpage>&#x02013;<lpage>1140</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4269/ajtmh.14-0211">10.4269/ajtmh.14-0211</ext-link></comment>
<?supplied-pmid 25846291?><pub-id pub-id-type="pmid">25846291</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name><surname>Nougairede</surname><given-names>A</given-names></name>, <name><surname>Cassadou</surname><given-names>S</given-names></name>, <name><surname>Prat</surname><given-names>C</given-names></name>, <name><surname>de Lamballerie</surname><given-names>X</given-names></name>. <article-title>Chikungunya in the Americas</article-title>. <source>The Lancet</source>. <year>2014</year>;<volume>383</volume>: <fpage>514</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(14)60185-9">10.1016/S0140-6736(14)60185-9</ext-link></comment></mixed-citation></ref><ref id="pntd.0006239.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Gallian</surname><given-names>P</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name><surname>Richard</surname><given-names>P</given-names></name>, <name><surname>Maire</surname><given-names>F</given-names></name>, <name><surname>Flusin</surname><given-names>O</given-names></name>, <name><surname>Djoudi</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2017</year>;<volume>11</volume>: <fpage>e0005254</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pntd.0005254">10.1371/journal.pntd.0005254</ext-link></comment>
<?supplied-pmid 28081120?><pub-id pub-id-type="pmid">28081120</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Paupy</surname><given-names>C</given-names></name>, <name><surname>Le Goff</surname><given-names>G</given-names></name>, <name><surname>Brengues</surname><given-names>C</given-names></name>, <name><surname>Guerra</surname><given-names>M</given-names></name>, <name><surname>Revollo</surname><given-names>J</given-names></name>, <name><surname>Barja Simon</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Genetic structure and phylogeography of Aedes aegypti, the dengue and yellow-fever mosquito vector in Bolivia</article-title>. <source>Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis</source>. <year>2012</year>;<volume>12</volume>: <fpage>1260</fpage>&#x02013;<lpage>1269</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.meegid.2012.04.012">10.1016/j.meegid.2012.04.012</ext-link></comment>
<?supplied-pmid 22522103?><pub-id pub-id-type="pmid">22522103</pub-id></mixed-citation></ref><ref id="pntd.0006239.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Aquino Rojas</surname><given-names>E</given-names></name>, <name><surname>Rojas Cortez</surname><given-names>M</given-names></name>, <name><surname>Espinoza</surname><given-names>J</given-names></name>, <name><surname>Vallejo</surname><given-names>E</given-names></name>, <name><surname>Lozano</surname><given-names>D</given-names></name>, <name><surname>Torrico</surname><given-names>F</given-names></name>. <article-title>Caracterizaci&#x000f3;n de la infestaci&#x000f3;n de viviendas por Aedes aegypti en el &#x000e1;rea metropolitana de Cochabamba, Bolivia: nuevos registros altitudinales</article-title>. <source>Gac M&#x000e9;dica Boliv</source>. <year>2016</year>;<volume>39</volume>: <fpage>83</fpage>&#x02013;<lpage>87</lpage>.</mixed-citation></ref><ref id="pntd.0006239.ref028"><label>28</label><mixed-citation publication-type="other">El Sedes confirma presencia del mosquito transmisor de zika en Tarija [Internet]. [cited 31 Oct 2017]. Available: <ext-link ext-link-type="uri" xlink:href="http://elperiodico-digital.com/2016/02/17/el-sedes-confirma-presencia-del-mosquito-transmisor-de-zika-en-tarija/">http://elperiodico-digital.com/2016/02/17/el-sedes-confirma-presencia-del-mosquito-transmisor-de-zika-en-tarija/</ext-link></mixed-citation></ref><ref id="pntd.0006239.ref029"><label>29</label><mixed-citation publication-type="other">Hallan el mosquito del dengue en tres &#x000e1;reas urbanas de La Paz&#x02014;La Raz&#x000f3;n [Internet]. [cited 31 Oct 2017]. Available: <ext-link ext-link-type="uri" xlink:href="http://www.la-razon.com/sociedad/Alerta-hallan-mosquito-dengue-areas-urbanas-La_Paz_0_2396760317.html">http://www.la-razon.com/sociedad/Alerta-hallan-mosquito-dengue-areas-urbanas-La_Paz_0_2396760317.html</ext-link></mixed-citation></ref></ref-list></back></article>